Metraipolis › archive › dc_3fd9ff50402a

Efficacy of Contractility Modulation Therapy in Patients with Transthyretin Amyloid Cardiomyopathy, Mildly Reduced to Reduced EF and NYHA III and IV: A… — Europe PMC PMID:41149251

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41149251
DOI
10.3390/jcdd12100380
License (as archived)
solo-consultazione
Archived
2026-11-09T18:44:42.949Z
SHA-256 of the archived text
4e25ab5e702650fba0000142e6dd0459043d50b18260ff4dcc9e2e43450d6e32
Stable URL of this page
https://metraipolis.com/documento/dc_3fd9ff50402a

How to cite

Efficacy of Contractility Modulation Therapy in Patients with Transthyretin Amyloid Cardiomyopathy, Mildly Reduced to Reduced EF and NYHA III and IV: A… — Europe PMC PMID:41149251 — Europe PMC (en), https://europepmc.org/article/MED/41149251 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fd9ff50402a (Metraipolis archive dc_3fd9ff50402a, sha256 4e25ab5e702650fba0000142e6dd0459043d50b18260ff4dcc9e2e43450d6e32)
BibTeX
@misc{dc3fd9ff50402a,
  title = {Efficacy of Contractility Modulation Therapy in Patients with Transthyretin Amyloid Cardiomyopathy, Mildly Reduced to Reduced EF and NYHA III and IV: A… — Europe PMC PMID:41149251},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41149251},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fd9ff50402a; sha256 4e25ab5e702650fba0000142e6dd0459043d50b18260ff4dcc9e2e43450d6e32},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41149251. Agents can read the archived copy with the MCP tool read_document.